GKV Capital Management Co. Inc. acquired a new stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,500 shares of the technology company’s stock, valued at approximately $526,000.
Several other large investors have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB raised its position in Veeva Systems by 72.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock valued at $25,000 after purchasing an additional 50 shares during the last quarter. Centricity Wealth Management LLC purchased a new stake in shares of Veeva Systems in the fourth quarter valued at about $25,000. Smithfield Trust Co raised its holdings in shares of Veeva Systems by 145.5% in the fourth quarter. Smithfield Trust Co now owns 135 shares of the technology company’s stock valued at $27,000 after buying an additional 80 shares during the last quarter. Retirement Wealth Solutions LLC acquired a new stake in shares of Veeva Systems during the fourth quarter worth about $31,000. Finally, Avion Wealth grew its holdings in shares of Veeva Systems by 635.0% during the fourth quarter. Avion Wealth now owns 147 shares of the technology company’s stock worth $30,000 after buying an additional 127 shares during the last quarter. 88.20% of the stock is owned by institutional investors and hedge funds.
Veeva Systems Stock Down 0.8 %
Shares of NYSE:VEEV opened at $221.01 on Thursday. The company has a market capitalization of $35.96 billion, a P/E ratio of 54.57, a P/E/G ratio of 1.89 and a beta of 1.05. Veeva Systems Inc. has a 52-week low of $170.25 and a 52-week high of $258.93. The stock’s fifty day simple moving average is $228.12 and its 200-day simple moving average is $223.25.
Insider Buying and Selling at Veeva Systems
Analyst Ratings Changes
A number of analysts have weighed in on VEEV shares. Morgan Stanley increased their price objective on Veeva Systems from $195.00 to $201.00 and gave the stock an “underweight” rating in a research report on Thursday, March 6th. JPMorgan Chase & Co. lifted their price objective on shares of Veeva Systems from $218.00 to $249.00 and gave the company a “neutral” rating in a research report on Thursday, March 20th. Needham & Company LLC restated a “buy” rating and set a $270.00 price objective on shares of Veeva Systems in a research report on Thursday, March 6th. Scotiabank raised their target price on shares of Veeva Systems from $240.00 to $245.00 and gave the stock a “sector perform” rating in a research note on Thursday, March 6th. Finally, Robert W. Baird boosted their price target on shares of Veeva Systems from $283.00 to $285.00 and gave the stock an “outperform” rating in a research note on Thursday, March 6th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $256.32.
Read Our Latest Report on VEEV
Veeva Systems Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Stories
- Five stocks we like better than Veeva Systems
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Health Care Stocks Explained: Why You Might Want to Invest
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.